A Study of AK0529 in infants with Respiratory Syncytial Virus Infection

Registry ID

EUCTR2017-002028-26

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

Ark Biosciences Pty Ltd.

Start date

2018-03-12

Completion date

2019-04-09

Last update

2026-08-16

Conditions

• Respiratory Syncytial Virus Infection

Summary

To evaluate the safety and tolerability of single and multiple oral doses of AK0529 in infants hospitalised with RSV

Locations

• , , Poland

Related clinical trials

• Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
• A Phase III Study of Deuremidevir Hydrobromide for the Treatment of RSV Infection in Infants and Young Children
• Genotype and Disease Burden of RSV in Older Vietnamese Adults (RSV: Respiratory Syncytial Virus )

View on source registry